This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Oncodesign Precision Medicine. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Kenneth Christensen - Innovator in Precision Medicine
Introduction
Kenneth Christensen is an inventor based in Copenhagen, Denmark. He is currently associated with Oncodesign Precision Medicine, where he contributes to advancements in the field of precision medicine. Although he does not hold any granted patents, his work is focused on innovative solutions in medical research.
Latest Patent Applications
Kenneth's latest patent applications include "Macrocyclic LRRK2 Kinase Inhibitors," which describes compounds of formula (I) that are useful as LRRK2 kinase inhibitors. Another application is titled "New Macrocyclic LRRK2 Kinase Inhibitors," which also involves compounds of Formula (I). These applications reflect his commitment to developing new therapeutic options.
Conclusion
Kenneth Christensen is a dedicated inventor whose work in precision medicine aims to make significant contributions to healthcare. His ongoing research and patent applications highlight his innovative approach to tackling complex medical challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile